| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Strategic Purchasing |
|
Digg It - Strategic Purchasing
The traditional role of purchasing is to purchase materials conforming to specifications such as physical di According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product mensions and the lowest bids. Most organizations still view purchasing as a tactical one with a short sighte ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in d approach. The tactical role of purchasing is underlined by the fact that most firms don’t have purchasing lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. function in the corporate boardroom. Purchasing as a tactical function is confined to clerical processes su here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe h as bid invitation, order management and payment. But purchasing is a complex function that manages supplie d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro rs for operation, new product launches and market planning. The strategic role envisages supplier involvemen ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc t for increasing the efficiency of the business itself. This transition from tactical to strategic to engage easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi suppliers is a long term process and therefore considerable change management processes. The objective of s nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically trategic purchasing is to manage suppliers to reduce cost of materials and engage them in downstream process and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ es and also to reduce the cost of purchasing. The implementation of IT in purchasing enables automation of m ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ny of the processes such as bid management and evaluation, order management and payment processes such as ha ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ndling of invoices. The automation reduces errors in the purchase to pay cycle and increases process efficie dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ncy. With increased competition and globalization, strategic purchasing involves sourcing supplies at the g cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin lobal level to reduce costs, better quality products. The global sourcing enables a firm to forge long term tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen elationships with vendors who have the synergy and to share best practices and solutions. By having the supp t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel lier closely work with the firm, more products are launched quickly in the market and fewer inventories of f ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust inished products unsold are stored in warehouses. Strategic purchasing enables firms to enter the ecommerce y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products arena to source supplies online. According to Porter’s five forces theory, suppliers are seen as a force in . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de the success of a product or firm and they are classified as either weak or strong. A chain is as strong as i elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ts weakest link. Strategic purchasing integrates suppliers into the network and collaborates to develop them tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Fierce Conversations - Part III
|